Literature DB >> 7449813

Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.

H Ishii, K Itoh, T Nose.   

Abstract

Antihypertensive effects of nifedipine and hydralazine were investigated in normotensive rats, spontaneously hypertensive rats (SHR), DOCA-NaCl hypertensive rats and renal hypertensive rats all in a conscious state. The blood pressure fall after nifedipine 5 mg/kg p.o. was 22% of the initial value in normotensive rats, 49% in SHR, 53% in DOCA-NaCl hypertensive rats and 44% in renal hypertensive rats. Hydralazine in the same dose decreased the blood pressure by 40% in normotensive rats, 52% in SHR, 33% in DOCA-NaCl hypertensive rats and 54% in renal hypertensive rats. The selective action of nifedipine in hypertensive rats in contrast to normotensive rats seemed to be attributable to the different affinity for calcium ion of vascular smooth muscle of hypertensive rats as compared with that of normotensive rats. Also, the heart rate of hypertensive rats or normotensive rats was increased with nifedipine but less than with hydralazine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7449813     DOI: 10.1016/0014-2999(80)90365-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  No apparent role for T-type Ca²⁺ channels in renal autoregulation.

Authors:  Rasmus Hassing Frandsen; Max Salomonsson; Pernille B L Hansen; Lars J Jensen; Thomas Hartig Braunstein; Niels-Henrik Holstein-Rathlou; Charlotte Mehlin Sorensen
Journal:  Pflugers Arch       Date:  2015-12-14       Impact factor: 3.657

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.

Authors:  K Aoki; K Sato; Y Kawaguchi; M Yamamoto
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Behavioral performance effects of nifedipine in normotensive and renovascular hypertensive baboons.

Authors:  J S Turkkan; R D Hienz
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice.

Authors:  Sujay V Kharade; Swapnil K Sonkusare; Anup K Srivastava; Keshari M Thakali; Terry W Fletcher; Sung W Rhee; Nancy J Rusch
Journal:  Hypertension       Date:  2012-11-05       Impact factor: 10.190

6.  Cardiovascular pharmacology of nicardipine in animals.

Authors:  T Takenaka; M Asano; K Shiono; M Shibasaki; O Inagaki
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 7.  [Calcium antagonists in the therapy of hypertension].

Authors:  A Heidland; E Heidbreder; W H Hörl; R M Schäfer
Journal:  Klin Wochenschr       Date:  1983-07-01

Review 8.  Discovery and Development of Calcium Channel Blockers.

Authors:  Théophile Godfraind
Journal:  Front Pharmacol       Date:  2017-05-29       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.